Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Annals of Hematology|May 10, 2003
Efficacy and safety of splenectomy in adult chronic immune thrombocytopeniaC Zoghlami-Rintelen, A Weltermann, C Bittermann, et al.
Annals of Hematology|May 1, 1991
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemiaG Sunder-Plassmann, W Speiser, C Korninger, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolismR Vormittag, P Bencur, C Ay, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screeningI Pabinger, S Brücker, P A Kyrle, et al.
International Journal of Obesity (2005)|December 2, 2015
Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgeryL Ay, J Thaler, J-M Brix, et al.
Annals of Hematology|August 31, 1999
Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartmentP Meidlinger, P Knöbl, U Jäger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1996
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patientsM Födinger, C Mannhalter, I Pabinger, et al.
Hamostaseologie|September 19, 2009
[Austrian haemophilia registry: up-date 2008 ]S Reitter, R Sturn, W Streif, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Sonography and scintigraphy in the differential diagnosis of diffuse liver parenchymal diseases]G Sommer, H Czembirek, H Leitner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 1999
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase geneC Rintelen, C Mannhalter, K Lechner, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Annals of Hematology|May 10, 2003
Efficacy and safety of splenectomy in adult chronic immune thrombocytopeniaC Zoghlami-Rintelen, A Weltermann, C Bittermann, et al.
Annals of Hematology|May 1, 1991
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemiaG Sunder-Plassmann, W Speiser, C Korninger, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolismR Vormittag, P Bencur, C Ay, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screeningI Pabinger, S Brücker, P A Kyrle, et al.
International Journal of Obesity (2005)|December 2, 2015
Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgeryL Ay, J Thaler, J-M Brix, et al.
Annals of Hematology|August 31, 1999
Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartmentP Meidlinger, P Knöbl, U Jäger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1996
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patientsM Födinger, C Mannhalter, I Pabinger, et al.
Hamostaseologie|September 19, 2009
[Austrian haemophilia registry: up-date 2008 ]S Reitter, R Sturn, W Streif, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Sonography and scintigraphy in the differential diagnosis of diffuse liver parenchymal diseases]G Sommer, H Czembirek, H Leitner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 1999
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase geneC Rintelen, C Mannhalter, K Lechner, et al.
Pageof 22